Upgrade to SI Premium - Free Trial

H.C. Wainwright Reiterates Buy Rating on Incyte (INCY)

April 15, 2026 7:18 AM
H.C. Wainwright analyst Mitchell Kapoor reiterated a Buy rating and $135.00 price target on Incyte (NASDAQ: INCY).The analyst commented: "Povorcitinib ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments